Trial Profile
Immune Response to Pneumococcal Vaccination in Aging HIV Positive Individuals
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Pneumococcal 13-valent CRM197 vaccine conjugate (Primary) ; Pneumococcal vaccine (Primary)
- Indications Pneumococcal infections
- Focus Pharmacodynamics
- 12 Jun 2020 Status changed from recruiting to completed.
- 18 Apr 2019 Planned End Date changed from 30 Jun 2019 to 30 Mar 2020.
- 16 Apr 2019 Planned primary completion date changed from 30 Mar 2019 to 30 Mar 2020.